查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1771586

美國傷口凝膠市場規模、佔有率及趨勢分析報告，按產品、抗菌特性、應用、最終用途、購買模式、分銷管道、細分市場預測，2025-2033 年

U.S. Wound Gel Market Size, Share & Trends Analysis Report By Product (Dressings, Gels), By Antimicrobial Properties (Silver (Ag+), Non-Silver), By Application, By End-use, By Mode Of Purchase, By Distribution Channel, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

美國傷口凝膠市場規模與趨勢：

預計 2024 年美國傷口凝膠市場規模為 21.1 億美元，到 2033 年將達到 34.7 億美元，2025 年至 2033 年的複合年成長率為 5.71%。

這一成長主要源於慢性傷口患病率的上升、對先進創傷護理解決方案的需求不斷成長、老年人口的不斷成長，以及用於加速傷口癒合的水凝膠配方的持續創新。此外，向門診和居家照護的轉變以及支持性報銷政策也進一步推動了市場擴張。

根據美國人口普查局的數據，到2025年，人口中位數年齡預計將達到40歲，65歲及以上人口將達到約6000萬，佔總人口的18%。其中，80歲以上人口占4%。 2050年，老年人口預計將增加至8,000萬，佔65歲以上人口的25%，佔80歲以上人口的8%。

美國軍事和國防部門對傷口凝膠產品的需求不斷成長，已成為市場的主要驅動力，這主要源於戰鬥和野外作業的獨特高風險性質。軍事人員經常遭受撕裂傷、燒燙傷和深度傷口等創傷，並且在傳統外科手術難以獲得的惡劣環境中，他們需要快速、高效且抗感染的治療。在這些情況下，傷口凝膠提供了一種實用的解決方案；它們便於攜帶，易於塗抹，並提供保濕癒合環境，加速組織再生，同時最大限度地降低感染風險。

此外，美國國防部正在與生物技術公司合作開發先進的水凝膠配方，包括基於酵素和抗菌的傷口凝膠，專門用於戰場。例如，美國於2024年11月決定與總部位於劍橋的生物技術公司SolasCure合作，在軍事環境中評估該公司的傷口護理水凝膠Aurase傷口凝膠的效果。 Aurase傷口凝膠最初將採用源自蛆蟲的重組酵素talmase。這種酵素在酵素脫屑方面非常有效，可以去除壞死組織並準備傷口床，從而為傷口管理提供一種受生物啟發的解決方案，可支持自然癒合和替代療法。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國傷口凝膠市場變數、趨勢與範圍

  • 市場展望
    • 母市場展望
    • 補貼市場前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 美國傷口凝膠市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國傷口凝膠市場：產品評估與趨勢分析

  • 細分儀表板
  • 美國傷口凝膠市場波動分析
  • 美國傷口凝膠市場規模與產品趨勢分析（2021-2033）
  • 敷料
    • 水凝膠敷料
    • 凝膠纖維敷料
    • 其他
  • 凝膠

第5章美國傷口凝膠市場：抗菌性能評估與趨勢分析

  • 細分儀表板
  • 美國傷口凝膠市場波動分析
  • 2021-2033 年美國傷口凝膠市場規模及抗菌趨勢分析
  • 銀（Ag+）
  • 非銀

第6章美國傷口凝膠市場：應用評估與趨勢分析

  • 細分儀表板
  • 美國傷口凝膠市場波動分析
  • 美國傷口凝膠市場規模與應用趨勢分析（2021-2033）
  • 慢性傷口
    • 糖尿病足潰瘍（DFU）
    • 壓瘡
    • 腿部潰瘍
  • 急性傷口
    • 手術切口
    • 燒燙傷
    • 撕裂傷、擦傷

第7章美國傷口凝膠市場：通路評估與趨勢分析

  • 細分儀表板
  • 美國傷口凝膠市場波動分析
  • 2021 年至 2033 年美國傷口凝膠市場規模及通路趨勢分析
  • 線上
  • 離線

第8章美國傷口凝膠市場：購買模式評估與趨勢分析

  • 細分儀表板
  • 美國傷口凝膠市場波動分析
  • 美國傷口凝膠市場規模及趨勢分析（按購買方式），2021-2033 年
  • 處方箋
  • 無需處方箋

第9章美國傷口凝膠市場：最終用途估計和趨勢分析

  • 細分儀表板
  • 美國傷口凝膠市場波動分析
  • 美國傷口凝膠市場規模及趨勢分析（依最終用途），2021-2033 年
  • 醫院
  • 專科診所
  • 門診手術中心
  • 居家照護環境
  • 長期照護機構
  • 其他

第10章 競爭格局

  • 市場參與企業分類
  • 主要企業簡介
  • Company Share Analysis, 2024
    • Medline Industries, LP.
    • Coloplast Corp
    • Molnlycke Health Care AB
    • Solventum
    • Convatec Inc.
    • Cresilon
    • Smith+Nephew
    • B. Braun SE
    • DermaRite Industries, LLC.
    • Integra LifeSciences Corporation
    • Sanara MedTech Inc.
Product Code: GVR-4-68040-621-3

U.S Wound Gel Market Size & Trends:

The U.S. wound gel market size was estimated at USD 2.11 billion in 2024 and is expected to grow at a CAGR of 5.71% from 2025 to 2033 to reach USD 3.47 billion by 2033. This growth is attributed to the rising prevalence of chronic wounds, increasing demand for advanced wound care solutions, a growing elderly population, and continuous innovations in hydrogel formulations that enhance healing outcomes. In addition, the shift toward outpatient and home-based care and supportive reimbursement policies is further accelerating market expansion.

According to data from the U.S. Census Bureau, by 2025, the population's average age is expected to reach 40 years, with approximately 60 million individuals aged 65 years or older accounting for 18% of the total population. Among them, 4% will be 80 years or older. By 2050, the number of elderly individuals is projected to rise to 80 million, representing 25% of the population aged 65 and above, while those aged 80 and over will comprise 8%.

The increasing demand for wound gel products from the U.S. military and defense sector is emerging as a significant market driver, primarily due to combat and field operations' unique and high-risk nature. Military personnel are frequently exposed to traumatic injuries, including lacerations, burns, and deep wounds, which require immediate, efficient, and infection-resistant treatment in austere environments where traditional surgical care is not readily available. In such scenarios, wound gels offer a practical solution-they are portable, easy to apply, and provide moisture-retentive healing environments that promote faster tissue regeneration while minimizing infection risks.

Furthermore, the U.S. Department of Defense has collaborated with biotechnology firms to develop advanced hydrogel formulations, including enzyme-based or antimicrobial wound gels designed specifically for battlefield use. For instance, in November 2024, the U.S. Army partnered with SolasCure, a Cambridge-based biotechnology company, to evaluate the company's investigational wound care hydrogel, Aurase Wound Gel, in military settings. Aurase wound gel features a recombinant enzyme, tarumase, derived initially from maggots. This enzyme is highly effective in enzymatic debridement, removing dead tissue and preparing the wound bed, offering a biologically inspired solution for wound management that supports natural and alternative healing approaches.

U.S. Wound Gel Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. wound gel market report based on product, antimicrobial properties, application, distribution channel, mode of purchase, and end-use:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Dressings
    • Hydrogel dressing
    • Gelling fiber dressings
    • Others
  • Gels
  • Antimicrobial Properties Outlook (Revenue, USD Million, 2021 - 2033)
  • Silver (Ag+)
  • Non-Silver
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Chronic Wounds
    • Diabetic Foot Ulcers (DFUs)
    • Pressure Ulcers
    • Stage 1
    • Stage 2
    • Stage 3
    • Stage 4
    • Leg Ulcers
  • Acute Wounds
    • Surgical Incisions
    • Burns
    • 1st Degree
    • 2nd Degree
    • 3rd Degree
    • Lacerations, Abrasions
  • Mode of Purchase Outlook (Revenue, USD Million, 2021 - 2033)
  • Prescription
  • Non-prescription
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Offline
  • Online
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgery Centers
  • Homecare Settings
  • Long-Term Care Facilities
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Antimicrobial Properties
    • 1.2.3. Application
    • 1.2.4. Distribution Channel
    • 1.2.5. Mode of Purchase
    • 1.2.6. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Wound Gel Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Shift towards home healthcare
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Rising Prevalence of Chronic Diseases
      • 3.2.1.4. Rising aging population in the U.S.
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent regulatory environment
      • 3.2.2.2. Limited reimbursement policies
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Increasing demand for wound gel products from the military and defense sector
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Rising competition among industry participants
  • 3.3. U.S. Wound Gel Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. U.S. Wound Gel Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Wound Gel Market Movement Analysis
  • 4.3. U.S. Wound Gel Market Size & Trend Analysis, by Product, 2021 - 2033 (USD Million)
  • 4.4. Dressings
    • 4.4.1. Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Hydrogel Dressing
      • 4.4.2.1. Hydrogel Dressing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Gelling Fiber Dressings
      • 4.4.3.1. Gelling Fiber Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Gels
    • 4.5.1. Gels Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Wound Gel Market: Antimicrobial Properties Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Wound Gel Market Movement Analysis
  • 5.3. U.S. Wound Gel Market Size & Trend Analysis, by Antimicrobial Properties, 2021 to 2033 (USD Million)
  • 5.4. Silver (Ag+)
    • 5.4.1. Silver (Ag+) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Non-Silver
    • 5.5.1. Non-Silver Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Wound Gel Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Wound Gel Market Movement Analysis
  • 6.3. U.S. Wound Gel Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Chronic Wounds
    • 6.4.1. Chronic Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. Diabetic Foot Ulcers (DFUs)
      • 6.4.2.1. Diabetic Foot Ulcers (DFUs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Pressure Ulcers
      • 6.4.3.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.4.3.2. Stage 1
        • 6.4.3.2.1. Stage 1 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.4.3.3. Stage 2
        • 6.4.3.3.1. Stage 2 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.4.3.4. Stage 3
        • 6.4.3.4.1. Stage 3 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.4.3.5. Stage 4
        • 6.4.3.5.1. Stage 4 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Leg Ulcers
      • 6.4.4.1. Leg Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Acute Wounds
    • 6.5.1. Acute Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. Surgical Incisions
      • 6.5.2.1. Surgical Incisions Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Burns
      • 6.5.3.1. Burns Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.5.3.2. 1st Degree
        • 6.5.3.2.1. 1st Degree Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.5.3.3. 2nd Degree
        • 6.5.3.3.1. 2nd Degree Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.5.3.4. 3rd Degree
        • 6.5.3.4.1. 3rd Degree Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. Lacerations, Abrasions
      • 6.5.4.1. Lacerations, Abrasions Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Wound Gel Market: Distribution Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Wound Gel Market Movement Analysis
  • 7.3. U.S. Wound Gel Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 7.4. Online
    • 7.4.1. Online Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Offline
    • 7.5.1. Offline Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. U.S. Wound Gel Market: Mode of Purchase Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. U.S. Wound Gel Market Movement Analysis
  • 8.3. U.S. Wound Gel Market Size & Trend Analysis, by Mode of Purchase, 2021 to 2033 (USD Million)
  • 8.4. Prescription
    • 8.4.1. Prescription Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Non-prescription
    • 8.5.1. Non-prescription Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. U.S. Wound Gel Market: End Use Estimates & Trend Analysis

  • 9.1. Segment Dashboard
  • 9.2. U.S. Wound Gel Market Movement Analysis
  • 9.3. U.S. Wound Gel Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 9.4. Hospitals
    • 9.4.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5. Specialty Clinics
    • 9.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6. Ambulatory Surgery Center
    • 9.6.1. Ambulatory Surgery Center Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7. Homecare Settings
    • 9.7.1. Homecare Settings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.8. Long-Term Care Facilities
    • 9.8.1. Long-Term Care Facilities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.9. Others
    • 9.9.1. Long-term Care (residential living setting) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Participant Categorization
  • 10.2. Key Company Profiles
  • 10.3. Company Share Analysis, 2024
    • 10.3.1. Medline Industries, LP.
      • 10.3.1.1. Company Overview
      • 10.3.1.2. Financial Performance
      • 10.3.1.3. Product Benchmarking
      • 10.3.1.4. Strategic Initiatives
    • 10.3.2. Coloplast Corp
      • 10.3.2.1. Company Overview
      • 10.3.2.2. Financial Performance
      • 10.3.2.3. Product Benchmarking
      • 10.3.2.4. Strategic Initiatives
    • 10.3.3. Molnlycke Health Care AB
      • 10.3.3.1. Company Overview
      • 10.3.3.2. Financial Performance
      • 10.3.3.3. Product Benchmarking
      • 10.3.3.4. Strategic Initiatives
    • 10.3.4. Solventum
      • 10.3.4.1. Company Overview
      • 10.3.4.2. Financial Performance
      • 10.3.4.3. Product Benchmarking
      • 10.3.4.4. Strategic Initiatives
    • 10.3.5. Convatec Inc.
      • 10.3.5.1. Company Overview
      • 10.3.5.2. Financial Performance
      • 10.3.5.3. Product Benchmarking
      • 10.3.5.4. Strategic Initiatives
    • 10.3.6. Cresilon
      • 10.3.6.1. Company Overview
      • 10.3.6.2. Financial Performance
      • 10.3.6.3. Product Benchmarking
      • 10.3.6.4. Strategic Initiatives
    • 10.3.7. Smith+Nephew
      • 10.3.7.1. Company Overview
      • 10.3.7.2. Financial Performance
      • 10.3.7.3. Product Benchmarking
      • 10.3.7.4. Strategic Initiatives
    • 10.3.8. B. Braun SE
      • 10.3.8.1. Company Overview
      • 10.3.8.2. Financial Performance
      • 10.3.8.3. Product Benchmarking
      • 10.3.8.4. Strategic Initiatives
    • 10.3.9. DermaRite Industries, LLC.
      • 10.3.9.1. Company Overview
      • 10.3.9.2. Financial Performance
      • 10.3.9.3. Product Benchmarking
      • 10.3.9.4. Strategic Initiatives
    • 10.3.10. Integra LifeSciences Corporation
      • 10.3.10.1. Company Overview
      • 10.3.10.2. Financial Performance
      • 10.3.10.3. Product Benchmarking
      • 10.3.10.4. Strategic Initiatives
    • 10.3.11. Sanara MedTech Inc.
      • 10.3.11.1. Company Overview
      • 10.3.11.2. Financial Performance
      • 10.3.11.3. Product Benchmarking
      • 10.3.11.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. U.S. Wound Gel Market, by Product, 2021 - 2033 (USD Million)
  • Table 4. U.S. Wound Gel Market, by Antimicrobial Properties, 2021 - 2033 (USD Million)
  • Table 5. U.S. Wound Gel Market, by Application, 2021 - 2033 (USD Million)
  • Table 6. U.S. Wound Gel Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 7. U.S. Wound Gel Market, by Mode of Purchase, 2021 - 2033 (USD Million)
  • Table 8. U.S. Wound Gel Market, by End Use, 2021 - 2033 (USD Million)
  • Table 9. Participant's Overview
  • Table 10. Financial Performance
  • Table 11. Product Benchmarking
  • Table 12. Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Wound Gel Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 U.S. Wound Gel Market, for Product, 2021 - 2033 (USD Million)
  • Fig. 15 U.S. Wound Gel Market, for Dressings, 2021 - 2033 (USD Million)
  • Fig. 16 U.S. Wound Gel Market, for Hydrogel Dressing, 2021 - 2033 (USD Million)
  • Fig. 17 U.S. Wound Gel Market, for Gelling Fiber Dressings, 2021 - 2033 (USD Million)
  • Fig. 18 U.S. Wound Gel Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 19 U.S. Wound Gel Market, for Gels, 2021 - 2033 (USD Million)
  • Fig. 20 U.S. Wound Gel Market, for Antimicrobial Properties, 2021 - 2033 (USD Million)
  • Fig. 21 U.S. Wound Gel Market, for Silver (Ag+), 2021 - 2033 (USD Million)
  • Fig. 22 U.S. Wound Gel Market, for Non-Silver, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. Wound Gel Market, for Application, 2021 - 2033 (USD Million)
  • Fig. 24 U.S. Wound Gel Market, for Chronic Wounds, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. Wound Gel Market, for Diabetic Foot Ulcers (DFUs), 2021 - 2033 (USD Million)
  • Fig. 26 U.S. Wound Gel Market, for Pressure Ulcers, 2021 - 2033 (USD Million)
  • Fig. 27 U.S. Wound Gel Market, for Stage 1, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. Wound Gel Market, for Stage 2, 2021 - 2033 (USD Million)
  • Fig. 29 U.S. Wound Gel Market, for Stage 3, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. Wound Gel Market, for Stage 4, 2021 - 2033 (USD Million)
  • Fig. 31 U.S. Wound Gel Market, for Leg Ulcers, 2021 - 2033 (USD Million)
  • Fig. 32 U.S. Wound Gel Market, for Acute Wound, 2021 - 2033 (USD Million)
  • Fig. 33 U.S. Wound Gel Market, for Surgical Incisions, 2021 - 2033 (USD Million)
  • Fig. 34 U.S. Wound Gel Market, for Burns, 2021 - 2033 (USD Million)
  • Fig. 35 U.S. Wound Gel Market, for 1st Degree, 2021 - 2033 (USD Million)
  • Fig. 36 U.S. Wound Gel Market, for 2nd Degree, 2021 - 2033 (USD Million)
  • Fig. 37 U.S. Wound Gel Market, for 3rd Degree, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. Wound Gel Market, for Lacerations, Abrasions, 2021 - 2033 (USD Million)
  • Fig. 39 U.S. Wound Gel Market, for End Use, 2021 - 2033 (USD Million)
  • Fig. 40 U.S. Wound Gel Market, for Hospitals, 2021 - 2033 (USD Million)
  • Fig. 41 U.S. Wound Gel Market, for Specialty Clinics, 2021 - 2033 (USD Million)
  • Fig. 42 U.S. Wound Gel Market, for Ambulatory Surgery Centers, 2021 - 2033 (USD Million)
  • Fig. 43 U.S. Wound Gel Market, for Homecare Settings, 2021 - 2033 (USD Million)
  • Fig. 44 U.S. Wound Gel Market, for Long-Term Care Facilities, 2021 - 2033 (USD Million)
  • Fig. 45 U.S. Wound Gel Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 46 U.S. Wound Gel Market, for Distribution Channel, 2021 - 2033 (USD Million)
  • Fig. 47 U.S. Wound Gel Market, for Offline, 2021 - 2033 (USD Million)
  • Fig. 48 U.S. Wound Gel Market, for Online, 2021 - 2033 (USD Million)
  • Fig. 49 U.S. Wound Gel Market, for Mode of Purchase, 2021 - 2033 (USD Million)
  • Fig. 50 U.S. Wound Gel Market, for Prescription, 2021 - 2033 (USD Million)
  • Fig. 51 U.S. Wound Gel Market, for Non-prescription, 2021